TITLE

CORRECTIONS

PUB. DATE
July 2007
SOURCE
Mayo Clinic Proceedings;Jul2007, Vol. 82 Issue 7, p890
SOURCE TYPE
Academic Journal
DOC. TYPE
Correction notice
ABSTRACT
Several corrections to the articles are presented including "Smoking and Inflammatory Bowel Disease: A Meta-analysis" in the November 2006 issue, "Nonsurgical Management of Primary Hyperparathyroidism" in the March 2007 issue, and "Achieving Low-Density Lipoprotein Cholesterol Goals in High-Risk Patients in Managed Care: Comparison of Rosuvastatin, Atorvastatin, and Simvastatin in the SOLAR Trial" in the May 2007 issue.
ACCESSION #
25818082

 

Related Articles

  • Endothelial Dysfunction in Chronic Inflammatory Diseases. Steyers III, Curtis M.; Miller Jr., Francis J. // International Journal of Molecular Sciences;Jul2014, Vol. 15 Issue 7, p11324 

    Chronic inflammatory diseases are associated with accelerated atherosclerosis and increased risk of cardiovascular diseases (CVD). As the pathogenesis of atherosclerosis is increasingly recognized as an inflammatory process, similarities between atherosclerosis and systemic inflammatory diseases...

  • Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease.  // Inflammatory Bowel Disease Monitor;2012, Vol. 12 Issue 4, p161 

    The authors discuss the targeted gene approach that examines the association of Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6) on the early onset of Crohn's disease. They mention the consistent demonstration of the minor allele frequency. The authors further claim that...

  • Dyslipidemia and Inflammation in Patients with Inflammatory Bowel Disease. Karaahmet, Fatih; Basar, Omer; Coban, Sahin; Yuksel, Ilhami // Digestive Diseases & Sciences;Jun2013, Vol. 58 Issue 6, p1806 

    No abstract available.

  • Should patients with inflammatory bowel disease smoke? Holdstock, Greg; Savage, D.; Harman, M.; Wright, Ralph // British Medical Journal (Clinical Research Edition);2/4/1984, Vol. 288 Issue 6414, p362 

    Examines the smoking habits of patients with inflammatory bowel disease. Influence of smoking on the reduced risk of ulcerative colitis; Role of smoking on the pathological appearance of the disease; Explanation on the therapeutic aspects of smoking in inflammatory bowel disease.

  • Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients. Thapa, Sudeep; Hadid, Hiba; Imam, Waseem; Hassan, Ahmad; Usman, Muhammad; Jafri, Syed-Mohammed; Schairer, Jason; Thapa, Sudeep Dhoj // Digestive Diseases & Sciences;Oct2015, Vol. 60 Issue 10, p3062 

    Background: IBD patients are at increased risk of coronary artery disease in the absence of traditional risk factors. However, the disease-related risk factors remain poorly understood although increased inflammation seems to increase cardiovascular disease risk in IBD. Thrombocytes...

  • Smoking, sugar, and inflammatory bowel disease. Thornton, J.R.; Emmett, P.M.; Heaton, K.W. // British Medical Journal (Clinical Research Edition);6/15/1985, Vol. 290 Issue 6484, p1786 

    Examines the smoking behavior of patients with inflammatory bowel disease in relation to their dietary habits. Association between smoking and Crohn's disease; Evidence of greater consumption of refined sugar among patients with Crohn's disease regardless of smoking habits; Difference in the...

  • Dual effect of chronic nicotine administration: augmentation of jejunitis and amelioration of colitis induced by iodoacetamide in rats. Eliakim, R.; Karmeli, F.; Cohen, P.; Heyman, S. N.; Rachmilewitz, D. // International Journal of Colorectal Disease;Jan2001, Vol. 16 Issue 1, p14 

    Smoking has a dichotomous effect on inflammatory bowel disease, ameliorating disease activity in ulcerative colitis but having a deleterious effect on Crohn's disease. This effect is thought to be due to nicotine. We investigated the effect of chronic nicotine administration on the small and...

  • LDL subfractions in patients with myocardial infarction: effect of smoking and β-blocker treatment. Theodoraki, Theodora G.; Tsoukatos, Demokritos C.; Karabina, Sonia-Athena; Rallidis, Loukianos S.; Papageorgakis, Nikolaos H.; Tselepsis, Alexandros D. // Annals of Clinical Biochemistry;May2000, Vol. 37 Issue 3, p313 

    The aim of the present case-control study was to estimate, by density gradient ultracentrifugation, LDL heterogeneity in myocardial infarction, and to evaluate the effect of smoking and β-blocker treatment on LDL subfraction profile. Our results show that patients who survive myocardial...

  • Associations between the age at surgical repair in patients with abdominal aortic aneurysms and aortoiliac occlusive disease and smoking and dyslipidemia with reference to PONI--108C > T genotype. Strauss, Ewa; Waliszewski, Krzysztof; Majewski, Wacław; Pawlak, Andrzej L. // Acta Angiologica;2008, Vol. 14 Issue 4, p131 

    Background. The pathogenesis of abdominal aortic aneurysms (AAA) and aorta-lilac occlusive disease (A/OD) is multifactorial, and both genetic and environmental factors are involved in the initiation and progression of pathological changes in the aorta. This study is concerned with associations...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics